Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantation

Author:

Joshi Maansi1,Taper John1,Forsyth Cecily2,Rowlings Philip34,Campbell Philip5,Crispin Philip67,Harvey Michael8,Underhill Craig9,Bayley Angela10,Byth Karen10,Huang Gillian10,Hertzberg Mark1112

Affiliation:

1. Department of Haematology, Nepean Hospital, Kingswood, Australia;

2. Gosford Hospital, Gosford, Australia;

3. Calvary Mater Newcastle Hospital, Newcastle, Australia;

4. School of Medicine and Public Health, University of Newcastle, Newcastle, Australia;

5. Andrew Love Cancer Centre, University Hospital Geelong, Geelong, Australia;

6. The Canberra Hospital, Canberra, Australia;

7. Australian National University Medical School, Canberra, Australia;

8. Liverpool Hospital, Sydney, Australia;

9. Albury Wodonga Health Service and Border Oncology, Albury, Australia;

10. Westmead Hospital, Sydney, Australia;

11. Department of Haematology, Prince of Wales Hospital, Sydney, Australia;

12. University of NSW, Sydney, Australia

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3